Philip W. Friederich

Author

Also Known As

Marcel Levi, P Friederich, P W Friederich, P. Friederich, P. W. Friederich, Philip Friederich, Philip W Friederich, Philip W. Friederich

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

University of Amsterdam Amsterdam UMC Location University of Amsterdam Utrecht University University Medical Center Utrecht Erasmus MC

About

Philip W. Friederich is an author at University of Amsterdam specializing in medicine, thrombosis, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.6K
2	Engineering	1	1	130
3	Health Sciences	1	1	118
4	Public Health	1	1	320
5	Anesthesia	1	1	118

Philip W. Friederich

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial Philip W. Friederich, C. P. Henny, Embert J. Messelink, The Lancet UrologyMedicineFactor ViiSurgeryPharmacotherapy	2003	413
Incidence of Venous Thromboembolism in Families with Inherited Thrombophilia Paolo Simioni, Bernd‐Jan Sanson, Daniela Tormene, Thrombosis and Haemostasis ThrombosisFamily MedicinePulmonary EmbolismVenous ThrombosisCardiovascular Disease	1999	320
Letrozole, a new oral aromatase inhibitor: Randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer M. Gershanovich, H.A. Chaudri, Diogo Ayres‐de‐Campos, Annals of Oncology Advanced Breast CancerBreast OncologyOncologyMedicineAromatase	1998	263
Frequency of Pregnancy-Related Venous Thromboembolism in Anticoagulant Factor-Deficient Women: Implications for Prophylaxis Philip W. Friederich Annals of Internal Medicine	1996	222
Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor. Monique C. Minnema, Philip W. Friederich, Marcel Levi, Journal of Clinical Investigation Fibrinolytic ActivityImmunologyBiomedical EngineeringAnti-fibrinolytic FactorInflammation	1998	184
The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. Bernd Jan Sanson, Paolo Simioni, Daniela Tormene, PubMed	1999	178
Role of colonoscopic biopsy in distinguishing between Crohn’s disease and intestinal tuberculosis R. E. Kirsch, Michelle Pentecost, Pauline de la Μ. Hall, Journal of Clinical Pathology	2006	134
Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits Marcel M. Levi, Philip W. Friederich, Sarah Middleton, Nature Medicine ThrombosisEngineeringBlood PlateletPlatelet ConcentratesHematology	1999	130
Patient‐controlled analgesia versus continuous infusion of morphine during vaso‐occlusive crisis in sickle cell disease, a randomized controlled trial Eduard J. van Beers, Charlotte F.J. Van Tuijn, Pythia T. Nieuwkerk, American Journal of Hematology Pain DisordersCumulative Morphine ConsumptionAcute PainPain MedicinePharmacotherapy	2007	118
Activation of Coagulation by Administration of Recombinant Factor VIIa Elicits Interleukin 6 (IL-6) and IL-8 Release in Healthy Human Subjects Evert de Jonge, Philip W. Friederich, George P. Vlasuk, Clinical and Vaccine Immunology ImmunologyImmune RegulationPathologyImmune SystemInflammation	2003	97

Page 1